Organovo Holdings, Inc. (ONVO)

[WHP03]

The technicals make me nervous as well. It's trading below it's 35 and 50 day MA (although not by much, $4.19 and $4.12 respectively), but clearly above it's 200, while straddling the 10 day. It feels like it's building a strong base around $3.80-3.85. When it took off last it launched from around $2.60 and ran up to $4.80ish. I think your last comment about increasing revenue and a strong tech (and team) are what assures a long-term excellent outcome. Revenue growth, the addition of new customers for liver and now kidney, more peer reviewed papers, and increasing adoption of 3D over 2D and animal testing will cure any 'chart ills' we see in the short-term.